Norges Bank X4 Pharmaceuticals, Inc Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2023	BUY	$1.48 - $2.58 $40,996 - $71,466	27,700 New	27,700 $48,000
Q1 2022 May 09, 2022	SELL	$1.48 - $2.58 $40,996 - $71,466	-27,700 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$1.9 - $5.6 $52,630 - $155,120	27,700 New	27,700 $63,000
Q3 2021 Nov 14, 2022	BUY	$4.53 - $6.45 $125,481 - $178,665	27,700 New	27,700 $147,000

103

99.9M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $54.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.